Guolian: It is the right time for domestic medical instruments to go global. Focus on leading companies with first-mover advantages in going abroad.

Domestic medical instruments have advantages in production, manufacturing, and upgrades, laying a foundation for products to go global, and the Global medical instruments market has vast potential.

Zhitong FinanceJan 2 02:02 ET

Micro-Tech (688029.SH): plans to use a maximum of no more than 0.2 billion yuan of idle raised funds for cash management.

On December 24, Glonghui reported that Micro-Tech (688029.SH) announced that considering the completed construction projects of production bases and the impending completion of research and experimental center construction projects, some of which have signed contracts but have not yet made payments, there is a need to continue to store and manage the raised funds until the relevant payments are completed. Therefore, it is agreed that the company may use idle raised funds for cash management, up to a maximum of 200 million yuan (including the principal), ensuring that it does not affect the subsequent payments of the company's investment projects, for the purpose of purchasing safe, liquid capital-preserving investment products (including but not limited to).

Gelonghui FinanceDec 24, 2024 07:18 ET

Despite Delivering Investors Losses of 55% Over the Past 3 Years, Micro-Tech (Nanjing)Ltd (SHSE:688029) Has Been Growing Its Earnings

Simply Wall StDec 11, 2024 19:22 ET

Private Companies Are Micro-Tech (Nanjing) Co.,Ltd's (SHSE:688029) Biggest Owners and Were Hit After Market Cap Dropped CN¥1.1b

Simply Wall StNov 19, 2024 01:28 ET

Nanwei Medical Technology Co., Ltd. Report for the Third Quarter of 2024

SZSIOct 29, 2024 12:00 ET · Announcements

micro-tech (688029.SH): The net income in the first three quarters is approximately 0.451 billion yuan, an increase of 16.7% year-on-year.

Grain News Oct 29th | Micro-Tech (688029.SH) announced that in the first three quarters of 2024, revenue was approximately 2.012 billion yuan, an increase of 15.3% year-on-year; net income attributable to shareholders of the listed company was approximately 0.451 billion yuan, an increase of 16.7% year-on-year; basic earnings per share were 2.41 yuan.

Gelonghui FinanceOct 29, 2024 11:23 ET